Results 251 to 260 of about 260,030 (390)
ALKBH8-mediated codon-specific translation promotes colorectal tumorigenesis. [PDF]
Qian Y +11 more
europepmc +1 more source
What's New? Prognostic assessment in metastatic colorectal cancer (mCRC), which is currently based on scores derived from clinical trials, requires refinement to enhance treatment outcomes and quality of care. In this study, the authors evaluated real‐world data from the German tumor registry to prospectively validate a modified mCRC prognostic score ...
Karin Potthoff +19 more
wiley +1 more source
TIMP-1 Modulation Correlates with KRAS Dependency and EMT Induction in NSCLC. [PDF]
M-Thirusenthilarasan I +8 more
europepmc +1 more source
New cell lines expanding the diversity of Ewing sarcoma models
What's New? A chromosomal translocation between the EWSR1 and ETS genes is the key oncogenic driver in Ewing sarcoma. EWSR1::FLI1, the most frequent fusion, is subdivided into different fusion types with unclear prognostic relevance. Here, the authors describe the establishment and characterization of four new, intrinsically immortal, patient‐derived ...
Maximilian Kerkhoff +13 more
wiley +1 more source
Molecular screening of natural compounds targeting KRAS(G12C): a multi-parametric strategy against acute lymphoblastic leukemia. [PDF]
Peng J +5 more
europepmc +1 more source
TBCancer: A database for exploring characteristics and functions of tissue‐biased genes in cancer
This study defined 10,921 tissue‐biased genes across 54 normal tissues and 41 cancer types. Tumor‐associated tissue‐biased genes exhibit downregulation, mutations, and epigenetic modifications, correlating with poor clinical outcomes. Their inactivation promotes tumorigenesis by enhancing stemness and immune evasion, highlighting their value as ...
Zhuobin Lin +7 more
wiley +1 more source
KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma. [PDF]
Jia D +8 more
europepmc +1 more source
USP28 Promotes Osimertinib Resistance in H1975 NSCLC Cells by Deubiquitinating and Stabilizing SIRT1
ABSTRACT Osimertinib (OSI) resistance in non‐small cell lung cancer (NSCLC) remains a significant challenge. This report explored the precise role of USP28 on OSI resistance in NSCLC and identified a functional downstream effector. OSI‐resistant H1975 cells (H1975/OSI) were established by long‐term OSI exposure.
Hu‐Sen Fan +4 more
wiley +1 more source

